169 related articles for article (PubMed ID: 11118314)
1. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
[TBL] [Abstract][Full Text] [Related]
2. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of class II trans-activator function by HIV-1 tat in mouse cells is independent of competition for binding to cyclin T1.
Mudhasani R; Fontes JD
Mol Immunol; 2002 Jan; 38(7):539-46. PubMed ID: 11750655
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells.
Sarol LC; Imai K; Asamitsu K; Tetsuka T; Barzaga NG; Okamoto T
Biochem Biophys Res Commun; 2002 Mar; 291(4):890-6. PubMed ID: 11866448
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Tosi G; Pilotti E; Mortara L; De Lerma Barbaro A; Casoli C; Accolla RS
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12861-6. PubMed ID: 16908858
[TBL] [Abstract][Full Text] [Related]
6. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.
Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM
Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines.
Tosi G; De Lerma Barbaro A; D'Agostino A; Valle MT; Megiovanni AM; Manca F; Caputo A; Barbanti-Brodano G; Accolla RS
Eur J Immunol; 2000 Jan; 30(1):19-28. PubMed ID: 10602023
[TBL] [Abstract][Full Text] [Related]
8. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
Kanazawa S; Okamoto T; Peterlin BM
Immunity; 2000 Jan; 12(1):61-70. PubMed ID: 10661406
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
10. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
Marcello A; Zoppé M; Giacca M
IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
[TBL] [Abstract][Full Text] [Related]
11. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
13. Class II transactivator suppresses transcription of thyroid-specific genes.
Mori-Aoki A; Pietrarelli M; Nakazato M; Caturegli P; Kohn LD; Suzuki K
Biochem Biophys Res Commun; 2000 Nov; 278(1):58-62. PubMed ID: 11071855
[TBL] [Abstract][Full Text] [Related]
14. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
[TBL] [Abstract][Full Text] [Related]
15. Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.
Kohoutek J; Blazek D; Peterlin BM
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17349-54. PubMed ID: 17088550
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
Radosevich M; Jager M; Ono SJ
Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
[TBL] [Abstract][Full Text] [Related]
17. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
Meissner M; Whiteside TL; Kaufmann R; Seliger B
Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 Tat transactivator protein: a therapeutic target?
Fulcher AJ; Jans DA
IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
[TBL] [Abstract][Full Text] [Related]
19. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
20. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]